|
TTPAL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.286200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.636600E-01 |
| Normal-vs-Stage2 |
7.816800E-01 |
| Normal-vs-Stage3 |
3.665600E-01 |
| Normal-vs-Stage4 |
5.282600E-01 |
| Stage1-vs-Stage2 |
7.856000E-01 |
| Stage1-vs-Stage3 |
3.829600E-01 |
| Stage1-vs-Stage4 |
6.272600E-01 |
| Stage2-vs-Stage3 |
7.044000E-01 |
| Stage2-vs-Stage4 |
5.602000E-01 |
| Stage3-vs-Stage4 |
3.304200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.783600E-01 |
| Normal-vs-AfricanAmerican |
8.204200E-01 |
| Normal-vs-Asian |
4.899600E-01 |
| Caucasian-vs-AfricanAmerican |
4.600600E-01 |
| Caucasian-vs-Asian |
9.102800E-01 |
| AfricanAmerican-vs-Asian |
7.368000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.268000E-01 |
| Normal-vs-Female |
3.941600E-02 |
| Male-vs-Female |
2.430100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.628800E-01 |
| Normal-vs-Extreme_Weight |
3.535600E-01 |
| Normal-vs-Obese |
2.480000E-01 |
| Normal-vs-Extreme_Obese |
3.703900E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.589200E-01 |
| Normal_Weight-vs-Obese |
4.193000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.092000E-01 |
| Extreme_Weight-vs-Obese |
7.598000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.242200E-01 |
| Obese-vs-Extreme_Obese |
1.124220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.954100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.039240E-01 |
| Normal-vs-Age(61-80Yrs) |
6.825000E-01 |
| Normal-vs-Age(81-100Yrs) |
1.600740E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.162000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.194150E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.845600E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.289600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.370390E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.687700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.703800E-01 |
| Normal-VS-Type2 PRCC |
1.611450E-01 |
| Normal-VS-KIRP CIMP |
3.965900E-02 |
| Normal-VS-Unclassified PRCC |
3.349600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.963700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.816100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
6.420200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.963700E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.255800E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
5.057600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.717190E-01 |
| Normal-vs-N1 |
9.865700E-02 |
| Normal-vs-N2 |
5.004200E-02 |
| N0-vs-N1 |
1.091580E-02 |
| N0-vs-N2 |
4.880800E-01 |
| N1-vs-N2 |
1.341960E-01 |
|
|
